Insider Transactions in Q1 2023 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2023
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,559
-1.39%
|
$20,267
$13.33 P/Share
|
|
Mar 14
2023
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,209
-1.82%
|
$15,717
$13.33 P/Share
|
|
Mar 14
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,311
-2.33%
|
$17,043
$13.33 P/Share
|
|
Mar 14
2023
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,416
-1.57%
|
$18,408
$13.33 P/Share
|
|
Mar 14
2023
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
7,318
-2.22%
|
$95,134
$13.33 P/Share
|
|
Mar 14
2023
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,441
-7.43%
|
$96,733
$13.33 P/Share
|
|
Mar 13
2023
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.48%
|
$13,000
$13.0 P/Share
|
|
Jan 18
2023
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-12.89%
|
$140,000
$14.03 P/Share
|
|
Jan 18
2023
|
Jonathan Mc Neill Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+11.42%
|
$0
$0.73 P/Share
|
|
Jan 09
2023
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
30,150
-30.84%
|
$331,650
$11.57 P/Share
|